Core Viewpoint - Rosen Law Firm is reminding investors who purchased Ardent Health, Inc. securities between July 18, 2024, and November 12, 2025, of the March 9, 2026, deadline to become a lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Ardent Health securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3]. - To serve as lead plaintiff, individuals must file a motion with the Court by March 9, 2026 [3]. Group 2: Case Background - The lawsuit alleges that Ardent Health made misrepresentations regarding its accounts receivable, claiming an active monitoring process that was not actually employed [5]. - Defendants reportedly downplayed increased claim denials by third-party payors and did not write off uncollectible accounts, which inflated reported accounts receivable [5]. - The firm did not maintain sufficient professional malpractice liability insurance, contrary to its representations, leading to potential investor damages when the truth was revealed [5].
ARDT DEADLINE NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Ardent Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 9 Deadline in Securities Class Action - ARDT